title: [Focal dystonias and their treatment with dysport (botulinum toxin type A)].
authors.forename: O R
authors.initials: OR
authors.lastname: Orlova
authors.forename: S L
authors.initials: SL
authors.lastname: Timerbaeva
authors.forename: S E
authors.initials: SE
authors.lastname: Khat'kova
authors.forename: V V
authors.initials: VV
authors.lastname: Kotliarov
authors.forename: L A
authors.initials: LA
authors.lastname: Korenko
authors.forename: Z A
authors.initials: ZA
authors.lastname: Zalialova
authors.forename: I V
authors.initials: IV
authors.lastname: Fal'kovskiĭ
authors.forename: L P
authors.initials: LP
authors.lastname: Shperling
authors.forename: L N
authors.initials: LN
authors.lastname: Antipova
authors.forename: E A
authors.initials: EA
authors.lastname: Antipenko
authors.forename: L R
authors.initials: LR
authors.lastname: Mingazova
authors.forename: M I
authors.initials: MI
authors.lastname: Soĭkher
authors.forename: D A
authors.initials: DA
authors.lastname: Krasavina
mesh_terms: D001764:Blepharospasm / Q000175:diagnosis / Q000188:drug therapy*; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use*; D020821:Dystonic Disorders / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D014103:Torticollis / Q000188:drug therapy
chemical_list: D019274:Botulinum Toxins, Type A; C542869:abobotulinumtoxinA